21st CENTURY CURES ACT

Amendments

Enact (H.R. 6), H5035, H5069, H5071, H5072, H5074, H5076, H5077, H5078 [10JY]

——— consideration (H. Res. 350), H4984 [9JY]

Bills and resolutions

Enact (see H.R. 6), H3386 [19MY]

Enact (H.R. 6): consideration (see H. Res. 350), H4954 [8JY]

Letters

Dept. of HHS outreach to minority-serving institutions and rural colleges to ensure that health professionals from under-represented populations are aware of research opportunities: Michael L. Lomax, United Negro College Fund, Inc., H5079 [10JY]

Provisions: Representative Lamar Smith, Committee on Science, Space, and Technology (House), H5009 [9JY]

——— Representative Paul Ryan, Committee on Ways and Means (House), H5009 [9JY]

——— Representative Upton, Committee on Energy and Commerce (House), H5009 [9JY]

Remarks in House

Abortion: prohibit taxpayer funded abortions, H4982, H5013, H5014 [9JY], H5072, H5073 [10JY], E1046 [13JY], E1069 [15JY]

Business and industry: exempt from manufacturer transparency reporting certain Social Security benefit transfers used for educational purposes, H4977 [9JY]

Centers for Disease Control and Prevention: conduct study to determine how efforts to incentivize development of new antibiotics may impact antibiotic resistance, H5074, H5075 [10JY]

Creating Hope Act: reauthorize, H4980 [9JY]

Dept. of HHS: conduct outreach to minority-serving institutions and rural colleges to ensure that health professionals from under-represented populations are aware of biomedical research opportunities, H5078–H5080 [10JY]

——— facilitate responsible dissemination of scientific and medical information not included in the approved labeling of drugs and devices, H4977 [9JY]

——— provide for research relative to Lyme disease and other tick-borne diseases, H5014 [9JY]

——— provide for systematic data collection and analysis and epidemiological research regarding multiple sclerosis, Parkinson’s disease, and other neurological diseases, H4977 [9JY]

Drugs: encourage development and use of new antimicrobial drugs in order to treat antibiotic-resistant infections, H5075 [10JY]

Enact (H.R. 6), H3399 [20MY], H3650 [2JN], H4476 [17JN], H4656 [25JN], H4972, H5008–H5016 [9JY], H5034, H5035–H5082, H5083, H5084 [10JY], H5094 [13JY], H5179, H5219 [15JY], H6219 [24SE], H7266 [28OC], H7399 [3NO], E1031, E1032, E1036–E1038 [10JY], E1045, E1046, E1047 [13JY], E1060, E1061 [14JY], E1069 [15JY]

——— consideration (H. Res. 350), H4976–H4985 [9JY]

FDA: establish streamlined data review program relative to approval of licensure of certain drugs, H4977 [9JY]

——— exempt certain user fees from budget sequestration, H5012 [9JY]

——— extend market exclusivity periods for drugs approved to prevent, diagnose, or treat a rare disease or condition, H5012 [9JY], E1037 [10JY]

——— issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy, H5077, H5078 [10JY]

——— provide for the regulation of health software, H5010 [9JY], E1061 [14JY]

——— reform program allowing for expanded access to certain experimental treatments or breakthrough drugs for seriously ill patients, H4980 [9JY]

Health: support the recording of Unique Device Identifiers at the point-of-care in electronic health record systems to enhance the availability of medical device data for post-market surveillance purposes, H5076, H5077 [10JY]

House of Representatives: remove Confederate flag from the House wing of the U.S. Capitol and any House office building, H4981–H4984 [9JY], E1046 [13JY]

Medicare: establish drug management program under part D to protect at-risk beneficiaries from controlled substance abuse, H4980 [9JY]

——— provide programs to prevent prescription drug abuse, E1037 [10JY]

Minorities: improve inclusion in clinical trials, H5012 [9JY]

NIH: establish medical prize program to incentivize health innovation by offering competitors the chance to win a prize for creating breakthrough research and technology, H5071, H5072 [10JY]

——— funding, H4981, H4982 [9JY]

——— include data on underrepresented groups, such as women and minorities, in report on efforts to attract, retain, and develop emerging scientists, H5074 [10JY]

——— make NIH and Cures Innovation Fund a discretionary spending program, H5069, H5070, H5075 [10JY], E1069 [15JY]

Reports filed

Consideration of H.R. 6, Provisions: Committee on Rules (House) (H. Res. 350) (H. Rept. 114–193), H4954 [8JY]

Provisions: Committee on Energy and Commerce (House) (H.R. 6) (H. Rept. 114–190), H4860 [7JY]

Texts of

H. Res. 350, consideration of H.R. 6, provisions, H4976 [9JY]

H.R. 6, provisions, H5035–H5069 [10JY]